BENGALURU: Indian drugmaker Dr Reddy’s Laboratories Ltd will launch its generic version of Merck’s antiviral COVID-19 pill, molnupiravir, under brand name ‘Molflu’ and will price it at 35 rupees ($0.4694) per capsule, a company spokesperson said on Tuesday., BENGALURU: Indian drugmaker Dr Reddy’s Laboratories Ltd will launch its generic version of Merck’s antiviral COVID-19 pill, molnupiravir, under brand name ‘Molflu’ and will price it at 35 rupees ($0.4694) per capsule, a company spokesperson said on Tuesday., , Read More

AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way